跳至主要内容
临床试验/NCT01528657
NCT01528657已完成不适用

Ventricular Pace Suppression Versus Intrinsic Rhythm Support Study

Biotronik SE & Co. KG20 个研究点 分布在 1 个国家目标入组 230 人开始时间: 2011年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
230
试验地点
20
主要终点
Ventricular pacing percentage

研究概览

简要总结

The objective of this study is to intra-individually compare the performances of two pacemaker algorithms designed to reduce unnecessary right ventricular pacing: Intrinsic Rhythm Support Plus (IRSplus) and Ventricular Pace Suppression (VpS). The study will compare ventricular pacing percentage, long-term atrio-ventricular conduction time, occurrences of atrial tachyarrhythmic events and atrial fibrillation burden percentage in patients implanted with a pacemaker for Sick Sinus Syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients over 18 years of age;
  • •Patient has proven informed consent;
  • •Subject with indication of dual chamber pacemaker due to Sinus Node Dysfunction;
  • •Subjects with a dual chamber pacemaker already implanted within six months from enrollment, provided that ventricular pacing percentage ≤ 40% and with the right ventricular lead in the apical position;
  • •Stable medical situation;
  • •Stable geographical situation;

排除标准

  • •Permanent or paroxysmal AV block ≥ II;
  • •Permanent Atrial fibrillation/Atrial flutter;
  • •Device Replacement;
  • •Patient with a poor echocardiographic window;
  • •Patient already implanted with the right ventricular lead not in the apical position;
  • •Subjects with a dual chamber pacemaker, implanted later than six months;
  • •Subjects with a dual chamber pacemaker with ventricular pacing percentage ≥ 40%;
  • •Contraindication for DDD(R)-ADI(R) or DDD(R) pacing modes;
  • •VpS or IRSplus algorithm contraindications;
  • •Age < 18 years;
  • •Life expectancy < 12 months;
  • •Cardiac surgery planned within the FU period;
  • •Participation to another clinical investigation;

研究组 & 干预措施

Ventricular Pace Suppression (VpS)

Experimental

The function Ventricular Pace Suppression (VpS) is activated

干预措施: Ventricular Pace Suppression (Vps) (Other)

Intrinsic Rhythm Support (IRSplus)

Experimental

The function Intrinsic Rhythm Support (IRSplus) is activated

干预措施: Intrinsic rhythm support (IRSplus) (Other)

结局指标

主要结局

Ventricular pacing percentage

时间窗: 6 months

次要结局

  • Burden of atrial fibrillation(6 Months)
  • Long-term atrio-ventricular conduction delay(6 Months)
  • Occurrence of atrial tachycardia or atrial fibrillation events(6 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (20)

Loading locations...

相似试验